Skip to main content
Fig. 2 | BMC Research Notes

Fig. 2

From: The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study

Fig. 2

Kaplan–Meier analysis of progression-free survival (left panels) and overall survival (right panels). Kaplan–Meier estimates of survivals according to the incidence of sunitinib-related hypertension (a, b), serum level of CRP (c, d) and sodium (e, f) at baseline. The time to the events is given in months

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us